Ginkgo Bioworks Holdings, Inc.
DNA Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Income
Balance Sheet
Cash Flow
DNA Income Statement
DNA Balance Sheet
DNA Cash Flow
Recent trades of DNA by members of U.S. Congress
DNA Stock Insider Trading Activity
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
DNA Stock Institutional Owners
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
DNA Derivatives Institutional Owners
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by DNA's directors and management
Government lobbying spending instances
-
$90,000 Oct 21, 2024 Issue: Medical/Disease Research/Clinical Labs Defense Budget/Appropriations
-
$90,000 Jul 22, 2024 Issue: Medical/Disease Research/Clinical Labs Defense Budget/Appropriations
-
$30,000 Jul 14, 2024 Issue: Agriculture
-
$90,000 Apr 21, 2024 Issue: Medical/Disease Research/Clinical Labs Defense Budget/Appropriations
-
$30,000 Apr 13, 2024 Issue: Agriculture
-
$10,000 Jan 22, 2024 Issue: Foreign Relations
-
$20,000 Oct 20, 2023 Issue: Foreign Relations
-
$30,000 Oct 18, 2023 Issue: Health Issues Defense
-
$90,000 Oct 16, 2023 Issue: Medical/Disease Research/Clinical Labs Defense Budget/Appropriations
-
$20,000 Jul 20, 2023 Issue: Foreign Relations
-
$90,000 Jul 16, 2023 Issue: Medical/Disease Research/Clinical Labs Defense Budget/Appropriations
-
$40,000 Jul 16, 2023 Issue: Agriculture Defense Science/Technology Health Issues
-
$30,000 Jul 12, 2023 Issue: Health Issues Defense
-
$20,000 Apr 20, 2023 Issue: Foreign Relations
-
$80,000 Apr 17, 2023 Issue: Agriculture Defense Science/Technology Health Issues
-
$10,000 Jan 20, 2023 Issue: Science/Technology Natural Resources Medical/Disease Research/Clinical Labs Defense
-
$80,000 Jan 15, 2023 Issue: Agriculture Defense Science/Technology Health Issues
-
$80,000 Oct 17, 2022 Issue: Agriculture Defense Education Science/Technology Health Issues
-
$10,000 Oct 17, 2022 Issue: Science/Technology Natural Resources Medical/Disease Research/Clinical Labs Defense
-
$10,000 Oct 17, 2022 Issue: Science/Technology Natural Resources Medical/Disease Research/Clinical Labs Defense
-
$80,000 Jul 16, 2022 Issue: Agriculture Defense Education Science/Technology Health Issues
-
$10,000 Jun 06, 2022 Issue: Defense Medical/Disease Research/Clinical Labs Natural Resources Science/Technology
-
$80,000 Apr 15, 2022 Issue: Health Issues Science/Technology Education Defense
-
$10,000 Jan 19, 2022 Issue: Defense Medical/Disease Research/Clinical Labs Science/Technology Natural Resources
-
$80,000 Jan 17, 2022 Issue: Health Issues Education Science/Technology Defense
-
$10,000 Oct 25, 2021 Issue: Science/Technology Natural Resources Medical/Disease Research/Clinical Labs Defense
-
$80,000 Oct 17, 2021 Issue: Health Issues Defense Education Science/Technology
-
$10,000 Jul 20, 2021 Issue: Medical/Disease Research/Clinical Labs Defense Science/Technology Natural Resources
-
$10,000 Jul 20, 2021 Issue: Medical/Disease Research/Clinical Labs Defense Science/Technology Natural Resources
-
$80,000 Jul 17, 2021 Issue: Education Health Issues Defense Science/Technology
-
$80,000 Apr 19, 2021 Issue: Education Defense Health Issues Science/Technology
-
$10,000 Feb 04, 2021 Issue: Defense Medical/Disease Research/Clinical Labs Science/Technology Natural Resources
-
$80,000 Jan 20, 2021 Issue: Budget/Appropriations Science/Technology Health Issues
-
$10,000 Dec 11, 2020 Issue: Natural Resources Science/Technology Medical/Disease Research/Clinical Labs Defense
-
$80,000 Oct 19, 2020 Issue: Science/Technology Health Issues Budget/Appropriations
-
$10,000 Aug 25, 2020 Issue: Natural Resources Science/Technology Defense Medical/Disease Research/Clinical Labs
-
$80,000 Jul 19, 2020 Issue: Health Issues Science/Technology
-
$10,000 May 11, 2020 Issue: Medical/Disease Research/Clinical Labs Defense Science/Technology Natural Resources
-
$40,000 Apr 20, 2020 Issue: Health Issues Science/Technology
-
$10,000 Mar 02, 2020 Issue: Natural Resources Science/Technology Defense Medical/Disease Research/Clinical Labs
-
$10,000 Oct 20, 2019 Issue: Natural Resources Science/Technology Medical/Disease Research/Clinical Labs Defense
Estimated quarterly lobbying spending
U.S. Patents
New patents grants
-
Patent Title: Virus vectors for targeting ophthalmic tissues Oct. 15, 2024
-
Patent Title: Antibody-evading virus vectors Sep. 17, 2024
-
Patent Title: Chimeric terpene synthases Sep. 03, 2024
-
Patent Title: Antibody-evading virus vectors Aug. 13, 2024
-
Patent Title: Recombinant adeno-associated virus vectors May. 14, 2024
-
Patent Title: Antibody-evading virus vectors May. 07, 2024
-
Patent Title: Adeno-associated viral vectors for treatment of niemann-pick disease type-c Feb. 20, 2024
-
Patent Title: Chemoautotrophic cells comprising an engineered carbon fixation pathway Jul. 11, 2023
-
Patent Title: Selective advantage in fermentation Jun. 13, 2023
-
Patent Title: Oleic acid production in yeast Apr. 25, 2023
-
Patent Title: Methods and compositions involving promoters derived from yarrowia lipolytica Feb. 07, 2023
-
Patent Title: Microorganisms engineered to use unconventional sources of phosphorous or sulfur Dec. 27, 2022
-
Patent Title: Increasing lipid production in oleaginous yeast Nov. 08, 2022
-
Patent Title: Compositions and methods for the production of compounds Oct. 25, 2022
-
Patent Title: Methods and systems for methylotrophic production of organic compounds Oct. 25, 2022
-
Patent Title: Compositions and methods for the production of compounds Sep. 20, 2022
-
Patent Title: Protective enzymes Jun. 14, 2022
-
Patent Title: Diacylglycerol acyltransferase (dga1) polynucleotides, and methods of increasing yeast cell lipid production by overexpression of heterologous dga1 Jun. 07, 2022
-
Patent Title: Biosynthesis of cannabinoids and cannabinoid precursors Mar. 15, 2022
-
Patent Title: Heterologous production of 10-methylstearic acid by cells expressing recombinant methyltransferase Feb. 01, 2022
-
Patent Title: Microorganisms engineered to use unconventional sources of nitrogen Jun. 22, 2021
-
Patent Title: Heterologous production of 10-methylstearic acid Apr. 13, 2021
-
Patent Title: Compositions and methods for the production of compounds Feb. 02, 2021
-
Patent Title: Methods for making chemoautotrophic cells by engineering an energy conversion pathway and a carbon fixation pathway Oct. 13, 2020
-
Patent Title: Methods and systems for cell state quantification Nov. 06, 2018
-
Patent Title: Methods and systems for chemoautotrophic production of organic compounds Feb. 27, 2018
-
Patent Title: Methods for preparative in vitro cloning Sep. 05, 2017
-
Patent Title: Methods and systems for cell state quantification Nov. 29, 2016
-
Patent Title: Methods and systems for chemoautotrophic production of organic compounds Jan. 08, 2013
Government Contracts
Federal grants, loans, and purchases
- $1,236,102 2024-09-06 00:00:00 Agency: Department of Health and Human Services
- $0 2024-09-06 00:00:00 Agency: Department of Health and Human Services
- $54,509,851 2024-08-26 00:00:00 Agency: Department of Health and Human Services
- $15,979,933 2022-08-16 00:00:00 Agency: DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS)
Government Contracts
Estimated quarterly amount awarded from public contracts
WallStreetBets
Number of mentions of DNA in WallStreetBets Daily Discussion
DNA News
Recent insights relating to DNA
CNBC Recommendations
Recent picks made for DNA stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in DNA
DNA Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view DNA Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More